Session information:
Date: October 15, 2026
Time: 9:00 am – 9:30 am ET
Session S14: AI and Digital Automation in Clinical Operations: Optimizing Trial Execution
Clario session: Minimizing Bias Risk when using AI with Pivotal Study Data
AI can help optimize clinical trial operations, enhance patient privacy, and improve data quality while reducing risk of human error. However, responsible deployment of AI is essential, to minimize risk for bias adversely impacting critical data and decision making. We will highlight the approach that one service provider has developed to responsibly create and deploy AI enabled tools, and how AI is being leveraged to identify ECG mislabeling to protect the integrity and quality of study data in clinical trials today.
Speaker
Vic Patel, M.D., Ph.D.
VP, Head of Scientific and Medical Affairs, Cardiac Science and Solutions at Clario, a part of Thermo Fisher Scientific
Dr. Vic Patel is board-certified in Cardiology with a PhD in Biophysics and has done extensive research on arrhythmia mechanisms. For 11 years, he served as a Faculty Member at U. Penn. School of Medicine, where he directed the Molecular Arrhythmia Research program and practiced clinical electrophysiology.
Dr. Patel spent the next eight years in drug development and cardiac safety as a Clinical Development Leader and therapy area head across all phases. At Clario, Dr. Patel oversees Cardiology Consulting, ECG/Holter core lab services and leads the Biostatistics and Medical writing groups.
Meet with us
Complete this form and we will reach out soon to schedule a time to connect at the event.
If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.